Not Yet RecruitingNot Applicable

BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis

United States30 participantsStarted 2026-02-16

Plain-language summary

This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.

Who can participate

Age range18 Years – 30 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Young adults aged 18-30 years * Diagnosis of early psychosis * Currently receiving outpatient care through an early psychosis clinic * Psychiatrically stable and deemed appropriate for participation by a treating clinician * Able and willing to provide informed consent Exclusion Criteria: * Unable to provide informed consent * Not fluent in English * History of antisocial behavior, as assessed at baseline * Immediate risk requiring a higher level of care

What they're measuring

Working Alliance Inventory - Short Revised (WAI-SR)

Timeframe: Baseline, Week 24

Trial details

NCT IDNCT07417904

SponsorHoward University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08

Contact for this trial

Stephanie Rolin, MD MPH

(202) 865-6100 stephanie.rolin@howard.edu

View on ClinicalTrials.gov More Violence Risk trials